Levetiracetam LEV CAS 102767-28-2 API Factory USP EP Kūlana Kiʻi Hoʻomaʻemaʻe Kiʻekiʻe

Levetiracetam LEV CAS 102767-28-2 Hale Hana API USP EP Maʻemaʻe Kiʻekiʻe

ʻO ka wehewehe pōkole:

Inoa Kemika: Levetiracetam;LEV

CAS: 102767-28-2

ʻAno: Keʻokeʻo a ʻaneʻane keʻokeʻo ka pauka

ʻIke: 98.0%~102.0%

Laau Antiepileptic o ka hanauna ekolu

API no ke kūlana kiʻekiʻe, hana kālepa

Inquiry: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Hāʻawi Mea Hana me ka Maʻemaʻe kiʻekiʻe a me ka maikaʻi paʻa
Inoa Kemika: Levetiracetam
CAS: 102767-28-2
API USP/EP maʻamau, Hana Kalepa
Laau Antiepileptic o ka hanauna ekolu

Na Waiwai Kemika:

Inoa Kimia	ʻO Levetiracetam
Nā huaʻōlelo like	LEV;(S)-2-(2-Oxo-1-pyrrolidinyl)butyramide;UCB-L059
Helu CAS	102767-28-2
Helu CAT	RF-API61
Kūlana Kūʻai	Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala	C8H14N2O2
Kaumaha Molecular	170.21
Lae hehee	116.0-119.0 ℃
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Keokeo a aneane keokeo ka pauda
ʻIkepili IR	Loaʻa ka Spectrum mai ka laʻana me ka mea i loaʻa mai ka mea kuhikuhi
ʻIke ʻia o ka Haʻina	Akaka a ʻaʻole i ʻoi aku ka ikaika ma mua o BY6
Enantiomeric Purity Impurity D	≤0.80%
Wai	≤0.50%
Lehu Sulfate	≤0.10%
Nā Metala Kaumaha	≤0.001%
Na mea pili
haumia A	≤0.30%
ʻO nā mea haumia ʻole i hōʻike ʻia	≤0.05%
Huina paumaele i hoakaka ole ia	≤0.10%
Huina paumaele	≤0.40%
haumia F	≤0.10%
Nā mea hoʻoheheʻe koena
Benzene	≤2ppm
Dichloromethane	≤600ppm
Ethyl Acetate	≤5000ppm
Acetone	≤5000ppm
Hoʻāʻo	98.0%~102.0%
Kūlana hoʻāʻo	USP Standard;EP Kūlana
Hoʻohana	API ʻEkolu-hanauna Laʻau Antiepileptic

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.

Pono:

FAQ:

Noi:

ʻO Levetiracetam (CAS: 102767-28-2), kahi huaʻōlelo o ka pilacetam, he lāʻau lapaʻau antiepileptic ʻekolu o ka hanauna i ʻae ʻia e ka US FDA ma 1999. Ua hoʻohana mua ʻia no ka hoʻoponopono hoʻohui ʻana i ka hopu ʻana i ka hapa i nā pākeke.I ka makahiki 2005, ua ʻae ʻia ʻo Levetiracetam i nā papa waha a me nā hoʻonā no ka hoʻoponopono hoʻohui ʻana i nā ʻāpana ʻāpana i nā keiki o 4 mau makahiki a keu.Hoʻohana nui ʻia ia no ka hoʻohui ʻana i ka hoʻomaʻamaʻa ʻana i nā ʻāpana ʻāpana i nā pākeke a me nā keiki ma mua o 4 mau makahiki, a hiki ke hoʻohana wale ʻia no nā ʻāpana ʻāpana a me nā ʻōnaehana systemic i nā pākeke.Loaʻa iā ia kekahi hopena curative ma ka myoclonic epilepsy i nā ʻōpio, refractory epilepsy, absent epilepsy i nā keiki a me ka epilepsy mau.